#obesity

#obesity

Semaglutide (Ozempic/Wegovy) may impact fertility due to its association with weight loss and metabolic improvements. [ more ]

GLP-1 receptor agonists like Ozempic aid weight loss

Exercise can help prevent weight regain after discontinuing GLP-1 receptor agonists [ more ]

Semaglutide may help people with HIV to lose weight and reduce fat accumulation.

Drugs like semaglutide could play a key role in managing metabolic issues caused by anti-HIV medications. [ more ]

Obesity can be seen as a disease that may require ongoing medical intervention, such as the use of weight loss drugs for long-term maintenance. [ more ]

Importance of studying body composition in addition to weight loss for new anti-obesity drugs

Existing focus on BMI in prescribing anti-obesity medications may not be sufficient to optimize overall health. [ more ]

Weight-loss drugs can only help patients lose weight to a certain point before hitting a plateau.

Recent advances in understanding gut hormones offer the potential for developing more powerful weight-loss drugs. [ more ]

Loneliness can lead to cravings for sugary foods, affecting mental health and body weight. [ more ]

Daily physical activity in the evening linked to the greatest health benefits for individuals with obesity.

Engaging in moderate to vigorous physical activity in the evening, even in short bouts, is crucial for reducing the risk of premature death and cardiovascular disease. [ more ]

Semaglutide has been approved by the FDA for weight loss in obese youngsters 12 and up.

Weight loss medications like Wegovy and Ozempic are being used to help teenagers struggling with obesity. [ more ]

GLP-1 receptor agonist medications like semaglutide can reduce the risk of cardiovascular disease in patients with obesity but no diabetes.

Weight-independent effects of semaglutide include reducing inflammation and improving vasculature and kidney health, leading to decreased development of cardiovascular events. [ more ]

Increased Kallistatin expression in subcutaneous white adipose tissue after weight loss

Kallistatin improves hepatic insulin sensitivity in diet-induced obese mice [ more ]

More seniors are being prescribed GLP-1 drugs for weight loss and diabetes management

The cost to Medicare of providing obesity drugs to seniors is a concern [ more ]

Obesity is associated with intrinsic metabolic abnormalities.

A single gene controls the process by which obesity affects mitochondria. [ more ]

The use of weight-loss medicines like semaglutide and tirzepatide is increasing in popularity due to their success in helping people lose weight.

These medications have been shown to have additional benefits for people with diabetes and cardiovascular disease. [ more ]

Food processing removes key components that regulate metabolism, contributing to obesity and diabetes.

Combination therapy with GLP-1 and GIP shows promise in promoting weight loss. [ more ]

Men in London's deprived boroughs are living nearly two years less than a decade ago.

Health experts attribute the decline in life expectancy to the impact of the Covid pandemic, rise in obesity, poverty, and long waits for NHS care. [ more ]

A new study found that providing free school meals for all primary school children in England reduces obesity and boosts reading skills.

Levels of obesity were reduced by 7% to 11% among reception children in the four London boroughs that have already adopted the policy.

Making free school meals universal increased their take-up by those who had already been entitled to them, possibly because it changed school culture and the stigma around having them. [ more ]

France is experiencing a boom in fast food establishments, with the number of fast food joints increasing from 44,000 in late 2019 to 52,500 in 2023.

The rise in fast food consumption is driven by the popularity of food delivery services, particularly among 18-24 year olds. [ more ]

Labour leader Keir Starmer announces plans for supervised toothbrushing in schools to tackle tooth decay in children.

The Labour Party's Child Health Action Plan includes banning flavoured vapes for children and implementing a junk food advertisement watershed at 21:00. [ more ]

As more people seek coverage for GLP-1 medications, employers are halting coverage due to rising costs.

Virta offers a cheaper alternative to GLP-1s through its virtual platform and nutritional therapy to reverse type 2 diabetes and obesity. [ more ]

Food is central to many people's lives, including during holiday celebrations.

The new obesity and diabetes medications can cause a loss of appetite, making food-focused holidays complicated for some.

People can lose their desire to eat due to reasons such as stress, grief, and illness. [ more ]

More than 1.5 billion adults and almost 400 million children will be living with obesity within 12 years if the condition isn't stopped.

The economic impact of obesity in the world will reach $4.32 trillion in losses annually by 2035.

Pharmaceutical companies see the fight against obesity as a lucrative market. [ more ]

New research suggests that weight influences how and when bodies burn energy.

People with a healthy weight use more energy during the day, while those with obesity spend more energy during the night.

The timing of when our bodies burn energy differs in those with obesity, but the reasons for this are still unclear. [ more ]